BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3718134)

  • 1. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
    Arsura EL; Bick A; Brunner NG; Namba T; Grob D
    Arch Intern Med; 1986 Jul; 146(7):1365-8. PubMed ID: 3718134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of age on extended thymectomy as a treatment for myasthenia gravis.
    Matsuzaki Y; Tomita M; Onitsuka T; Shibata K
    Ann Thorac Cardiovasc Surg; 1998 Aug; 4(4):192-5. PubMed ID: 9738119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of myasthenia gravis after removal of a thymoma having a membrane phenotype of suppressor T cells.
    Kuroda Y; Oda K; Neshige R; Shibasaki H
    Ann Neurol; 1984 Apr; 15(4):400-2. PubMed ID: 6234854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerulonephritis, thymoma and myasthenia gravis.
    Scadding GK; Sweny P; Wilson SG; Havard CW; Newsom-Davis J
    Q J Med; 1983; 52(206):187-93. PubMed ID: 6611840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
    J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of post-thymomectomy myasthenia gravis after extrapleural pneumonectomy for invasive thymoma which necessistated long-term mechanical ventilation].
    Nomori H; Horio H
    Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):66-70. PubMed ID: 11296390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
    Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymectomy in late-onset myasthenia gravis.
    Olanow CW; Lane RJ; Roses AD
    Arch Neurol; 1982 Feb; 39(2):82-3. PubMed ID: 7059304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma.
    Kim HK; Park MS; Choi YS; Kim K; Shim YM; Han J; Kim BJ; Kim J
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):601-7. PubMed ID: 17723805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose steroids for perioperative management of patients with myasthenia gravis undergoing thymectomy. A preliminary report.
    Bolooki H; Schwartzman RJ
    J Thorac Cardiovasc Surg; 1978 May; 75(5):754-7. PubMed ID: 642573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
    Pascuzzi RM; Coslett HB; Johns TR
    Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis.
    Kagotani K; Monden Y; Nakahara K; Fujii Y; Seike Y; Kitamura S; Masaoka A; Kawashima Y
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):7-12. PubMed ID: 4010323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymectomy in myasthenia gravis. A review.
    Oosterhuis HJ
    Ital J Neurol Sci; 1983 Dec; 4(4):399-407. PubMed ID: 6370908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.